Last updated:
5/7/2025
Years published: 1991, 1997, 2003, 2025
NORD gratefully acknowledges Gioconda Alyea, MD (FMG), MS, National Organization for Rare Disorders, for assistance in the preparation of this report.
Marcus Gunn phenomenon is a rare condition present at birth (congenital) where one upper eyelid moves when the jaw moves.1 This often looks like an involuntary “wink” or lift of the eyelid when a person chews, sucks, or moves their jaw in certain ways. Parents may first notice this movement when their baby is feeding.2
The exact cause is unknown, but experts believe it happens due to a miswiring between the nerves that control jaw movement and the muscles that lift the eyelid which is known as synkinesis.3 It usually affects just one eye, but in rare cases, both eyes can be involved.4
Many people with Marcus Gunn phenomenon don’t need treatment, especially if the eyelid movement is mild. However, if the condition affects vision or is a cosmetic concern, surgery may be an option.
This condition was first identified in 1883 by Dr. Robert Marcus Gunn, a Scottish eye doctor. It is considered part of a group of nerve-related eye movement disorders called congenital cranial dysinnervation disorders (CCDD).4
The unique characteristic of Marcus Gunn phenomenon is that the affected eyelid lifts quickly when the jaw moves, such as during chewing, sucking, smiling, or even swallowing.⁵ This “wink” tends to be more noticeable when looking downward.⁴ It results in drooping of one upper eyelid (unilateral blepharoptosis).
Parents often notice the eyelid movement while their baby is breastfeeding or bottle-feeding.
Common signs and symptoms include:2,4,6,7
Marcus Gunn phenomenon is sometimes linked to other eye conditions:4
Although most cases are detected in infancy, the syndrome can present at any age. Most cases affect only one side (unilateral) and it’s more common on the left side. Bilateral cases (both eyelids affected) are very rare.4
Marcus Gunn phenomenon is considered as one of the congenital cranial dysinnervation disorders (CCDD)4 which involve abnormal connections between cranial nerves, often resulting in synkinetic activation of specific muscles. A synkinetic movement or “simultaneous movement” is a neurological phenomenon where a voluntary facial muscle movement unintentionally triggers involuntary contractions in other facial muscles.
Normally, the levator palpebrae superioris muscle, responsible for raising the upper eyelid, is innervated by the oculomotor nerve (CN III), specifically its superior branch. The muscles of the jaw, including those involved in chewing, are innervated by the mandibular nerve, a branch of the trigeminal nerve. In Marcus Gunn phenomenon, these nerves are miswired, leading to a synkinetic movement where moving the jaw also causes the eyelid to move.⁸
In a few cases, the synkinetic movement occurs between the internal pterygoid and the levator palpebrae superioris (LPS) muscles. The internal pterygoid muscle is innervated by the medial pterygoid nerve, a branch of the mandibular nerve. In such cases, the eyelid elevates by closing the mouth and clenching the teeth.
It is not known why the abnormal connection occurs.4,9 This miswiring likely occurs during early fetal development, so Marcus Gunn phenomenon a congenital (present from birth) condition.
Familial cases with autosomal dominant inheritance have been described in the medical literature but are very rare.4 Most isolated Marcus Gunn phenomenon cases occur sporadically without a known genetic cause.¹⁰
Marcus-Gunn phenomenon can also occur as part of several syndromes caused by different gene variants including:10
Additionally, chromosomal abnormalities like 22q11.2 microduplication (duplication of the part of chromosome 22) and 7q11.23 gene deletion have been reported in complex Marcus Gunn phenomenon cases.
While Marcus Gunn phenomenon is typically congenital, there are a few reports of acquired cases after ocular trauma or complicated eye surgeries. In these situations, abnormal nerve regeneration may create a similar jaw-winking reflex.⁴
Marcus Gunn phenomenon is rare, with around 300 documented cases worldwide.¹¹ It affects males and females equally.11,12
The condition is usually noticed when parents observe the eyelid movement while the baby is breastfeeding or bottle-feeding.¹²
Among children with congenital ptosis (droopy eyelid present at birth), 2-13% are diagnosed with Marcus Gunn phenomenon.4
Doctors diagnose Marcus Gunn phenomenon by observing the distinctive eyelid movement when the jaw moves.⁴,5 They may also check for related eye conditions like lazy eye (amblyopia) or misaligned eyes (strabismus). ⁷
A full eye exam usually includes:⁷
The amount of “jaw-winking” is also measured:⁴
Doctors also check for Bell’s phenomenon, which is whether the eyes roll upward when closed as this reflex can be weak in certain conditions.
Treatment
For many people with Marcus Gunn phenomenon, treatment isn’t needed. The jaw-winking movement may become less noticeable with age, and mild cases might not cause any significant issues.⁶ However, if the ptosis (droopy eyelid) is severe or causes vision problems (like amblyopia), or is a cosmetic concern, treatment options including surgery, can be considered.⁶
Before considering surgery, it’s crucial to treat amblyopia (lazy eye) if it’s present. This might involve:
Clinical photos may be taken to monitor the condition over time.⁴
Close follow-up is essential to ensure the therapy is working and the child’s vision develops properly.⁴
Surgery is considered if the eyelid droop is severe, interferes with vision, or if the jaw-winking movement is very noticeable.⁷,¹⁰ Doctors usually wait until the child is at least 1–2 years old because anesthesia is safer after infancy.⁴
There are different surgical options to treat droopy eyelids (ptosis), depending on how severe it is.4
If the jaw-wink is too severe, surgeons may disable or remove the levator muscle to stop the abnormal movement.7
Like any surgery, eyelid procedures have risks, including:⁷
Regular follow-ups help monitor healing and address any complications.⁴
New ideas are emerging to improve Marcus Gunn phenomenon treatment. Researchers suggest exploring:7,10
Most people with Marcus Gunn phenomenon have a good prognosis. With careful monitoring and appropriate treatment, amblyopia can be successfully managed, and surgical outcomes can improve both function and appearance.⁴
Information on current clinical trials is posted on the Internet at https://clinicaltrials.gov/. All studies receiving U.S. Government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Toll-free: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]
Some current clinical trials also are posted on the following page on the NORD website:
https://rarediseases.org/living-with-a-rare-disease/find-clinical-trials/
For information about clinical trials sponsored by private sources, contact:
https://www.centerwatch.com/
For information about clinical trials conducted in Europe, contact:
https://www.clinicaltrialsregister.eu/

NORD strives to open new assistance programs as funding allows. If we don’t have a program for you now, please continue to check back with us.
NORD and MedicAlert Foundation have teamed up on a new program to provide protection to rare disease patients in emergency situations.
Learn more https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/Ensuring that patients and caregivers are armed with the tools they need to live their best lives while managing their rare condition is a vital part of NORD’s mission.
Learn more https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/This first-of-its-kind assistance program is designed for caregivers of a child or adult diagnosed with a rare disorder.
Learn more https://rarediseases.org/patient-assistance-programs/caregiver-respite/No patient organizations found related to this disease state.
The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.
The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).
View reportOrphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.
View reportOnline Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.
View reportPlease complete this form to access the requested resource.